Evidence map›Paper›PMID 40925915›Full record

ArticleNPJ precision oncology2025

Computational pathology annotation enhances the resolution and interpretation of breast cancer spatial transcriptomics data.

Tianyi Li, Qiao Yang, Balazs Acs, Emmanouil G Sifakis, Hosein Toosi, Camilla Engblom, Kim Thrane, Qirong Lin, Jeff E Mold, Wenwen Sun and 7 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Decoding the breast cancer microenvironment by spatial multi-omics: from architecture to clinical translation.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tianyi LiDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. tianyi.li.2@ki.se.
Qiao YangDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Balazs AcsDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Emmanouil G SifakisDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Hosein ToosiSciLifeLab, Department of Computation Science and Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Camilla EngblomDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Kim ThraneSciLifeLab, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Qirong LinDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Jeff E MoldDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Wenwen SunDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Ceren BoyaciDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Sanna SteenDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Jonas FrisénDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Jens LagergrenSciLifeLab, Department of Computation Science and Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Joakim LundebergSciLifeLab, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Xinsong Chen *Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. xinsong.chen@ki.se.
Johan Hartman *Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Funding

H2020 Marie Skłodowska-Curie Actions 844712Vetenskapsrådet 201806217_VR
6 · The paper itself

Abstract

Breast cancer is a highly heterogeneous disease with diverse outcomes, and intra-tumoral heterogeneity plays a significant role in both diagnosis and treatment. Despite its importance, the spatial distribution of intra-tumoral heterogeneity is not fully elucidated. Spatial transcriptomics has emerged as a promising tool to study the molecular mechanisms behind many diseases. It offers accurate measurements of RNA abundance, providing powerful tools to correlate the morphologies of cellular neighborhoods with localized gene expression patterns. However, the spot-based spatial transcriptomic tools, including the most widely used platform, Visium, do not achieve single-cell resolution readouts, which hinders data interpretability. In this study, we present a computational pathology image analysis pipeline (i.e., computational tissue annotation, CTA) that utilizes machine learning algorithms to accurately map tumor, stroma, and immune compartments within Visium-assayed tumor sections. Using a cohort of 23 breast tumor sections from four patients, we demonstrate that CTA can provide high-resolution annotations on the hematoxylin-and-eosin-stained images alongside the paired sequencing data, support the evaluation of deconvolution methods, deepen insights into intra-tumoral heterogeneity by increasing data analysis resolution, assist with spatially resolved intrinsic subtyping, and enhance the visualization of lymphocyte clones at single-cell resolution. The proposed pipeline provides valuable insights into the complex spatial architecture of breast cancer, contributing to more personalized diagnostics and treatment strategies.

Identifiers

PMID40925915
PMCPMC12420830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.